← FDA Drug Approvals (Drugs@FDA)

DOXYCYCLINE HYCLATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: LUPIN · Approved 2024-03-14

Drug application

FDA Application #

ANDA217794

Application type

Abbreviated New Drug Application (Generic)

Brand name

DOXYCYCLINE HYCLATE

Generic name

DOXYCYCLINE

Active ingredients

DOXYCYCLINE HYCLATE

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

LUPIN

Manufacturer

Lupin Pharmaceuticals, Inc.

First approval

2024-03-14

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown